Navigation Links
Landauer, Inc. Reports Fiscal 2011 Third Quarter Results
Date:8/9/2011

to Nagase Landauer, the Company's joint venture in Japan.

The effective tax rate was 32.9 percent and 31.2 percent for the first three quarters of fiscal 2011 and 2010, respectively.  Net income for the nine months ended June 30, 2011 was $19.4 million, an increase of 1 percent compared with $19.1 million for the nine months ended June 30, 2010.  The resulting diluted earnings per share for the first three quarters of fiscal 2011 were $2.05 compared with $2.04 for the same period in fiscal 2010.  Earnings before interest, taxes, depreciation and amortization ("EBITDA") were $33.1 million, a 5 percent increase compared with $31.6 million a year ago.  The increase is due primarily to the $1.5 million reduction in acquisition related transaction and reorganization costs for the first nine months of fiscal 2011.  A reconciliation of net income to EBITDA is included in the attached financial exhibits.

Radiation Monitoring SegmentRadiation Monitoring revenues for the first nine months of fiscal 2011 declined 1 percent, or $0.5 million, to $75.3 million.  Of the decline, $1.5 million is due to the previously reported change in the supply relationship between Landauer and Nagase Landauer, the Company's unconsolidated joint venture in Japan.  Without the Nagase Landauer impact, domestic Radiation Monitoring revenue declined 3 percent, or $1.5 million, driven by lower non-recurring InLight equipment sales, primarily to the Canadian government agency responsible for occupational monitoring and radiation emergency preparedness for the citizens of Canada.  International Radiation Monitoring revenue increased 13 percent, or $2.6 million, on $1.4 million of organic growth in most regions and $1.2 million from the strengthening of most foreign currencies against the dollar.

Radiation Monitoring gross margin for the nine months ended June 30, 2011 increased to 69 percent from 67 percent in the year ago period, p
'/>"/>

SOURCE Landauer, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2010 Results
2. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results
3. Landauer, Inc. Declares Regular Cash Dividend
4. Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2011 Results
5. Landauer, Inc. Declares Regular Cash Dividend
6. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Second Quarter 2011 Results
7. Landauer, Inc. Declares Regular Cash Dividend
8. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Third Quarter 2011 Results
9. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
10. Spherix Reports Second Quarter Earnings
11. Tapestry Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) announces that ... to the announced tender offer for all of the outstanding shares ... of the waiver, the transaction is no longer conditional on OFT ... 24, 2014 following the currently scheduled expiration time, subject to the ...
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and distributors ... able to protect their most important business assets, ... ) Because of the highly-competitive ... remains one of the most litigious industry sectors ...
(Date:1/15/2014)... , Jan. 15, 2014 MultiCell Technologies, Inc. ... a U.S. provisional patent application concerning composition of matter, ... achieve targeted tumor cell death.  This ... noncoding double stranded RNA molecules (VSRNAs) which interfere with ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... Hill-Rom Holdings, Inc., (NYSE: HRC ) invites you to listen to a ... the Goldman Sachs 31st Annual Global Health Care Conference in Los Angeles ... 10:40 a.m. PDT ).     , , ... invited to listen to the live discussion via the internet link at http://ir.hill-rom.com/events.cfm ...
... June 2 Today In the Face of ... help pain management advocates expand their outreach efforts through popular ... to social media applications, such as Facebook, and walks users ... communication vehicles. Topics include "An Overview of Social Media," "Advocacy ...
Cached Medicine Technology:Hill-Rom to Participate at the Goldman Sachs 31st Annual Global Health Care Conference 2In the Face of Pain® Offers Social Media 101 for Pain Management Advocates 2
(Date:4/17/2014)... million older Americans suffer from depression, often brought on ... research a project that followed the lives of ... found that Internet use among the elderly can reduce ... , "That,s a very strong effect," said Shelia Cotten, ... and media who led the project. "And it all ...
(Date:4/17/2014)... YORK April 17, 2014 EcoHealth Alliance, a ... health issues, published a comprehensive review today examining the ... Marburg virus. The review calls for improved global surveillance ... as the recent outbreak of Ebola in West Africa ... the countries of Guinea and Liberia. According to ...
(Date:4/17/2014)... uncommon these days to find a colored ribbon representing a ... cancer. But what color ribbon does one think of with ... color, for many suffering from the disease, black may be ... study consisting of lung cancer patients, primarily smokers between the ... light on the stigma often felt by these patients, the ...
(Date:4/17/2014)... TORONTO, April 17, 2014While 94 per cent of Canadians ... that screen newborns for a specific number of genetic ... willing to participate in screening that would sequence their ... prick test" in their first day or two of ... taken from their heels and tested for about five ...
(Date:4/16/2014)... the embryo. It begins as a glob of identical cells ... the cells of our lungs, muscles, nerves and all the ... feat of reverse tissue engineering, Stanford University researchers have begun ... to proliferate and transform into all of the specialized cells ...
Breaking Medicine News(10 mins):Health News:Internet use can help ward off depression among elderly 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Unraveling the 'black ribbon' around lung cancer 2Health News:Researcher looks at public perceptions around newborn testing 2Health News:Researcher looks at public perceptions around newborn testing 3Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 3
... Researchers have found that contacting with Age-related Macular Degeneration ... whose Body Mass Index is 30 or higher//. ... risk and high BMI (30 or higher) was associated ... risk genotype (CC) plus smoking conferred a tenfold higher ...
... transdermal system), formulated by Shire was the foremost patch ... ,Transdermal formulation of methylphenidate - DAYTRANA, is ... 10 mg, 15 mg, 20 mg and 30 mg. ... for ADHD, provides physicians and parents with a new, ...
... the National Health Service (NHS) information centre the Scots are ... and the number of NHS dentist//. ,They fear ... demand. The British Dental Association said that the NHS is ... the NHS information and statistics division, it is found that ...
... vaccines, each developed by Merck and Smith Glaxo Kline has ... cancers caused by the human papilloma viruses (HPVs). ... showed reduced infection in about 90% of the subjects. ... and immunologic technologies have contributed to the discovery of the ...
... Recent research has revealed that having several older brothers increases ... finding that adds //weight to the idea of a biological ... of Brock University in St Catharines, Canada said, "It's likely ... that there is probably a biological basis for homosexuality." ...
... and Pharmacovigilance said that FDA’s approval of REVLIMID ... the group of people suffering from multiple myeloma. ... the U.S. Food and Drug Administration (FDA) has ... (sNDA) for an additional indication for REVLIMID (lenalidomide), ...
Cached Medicine News:Health News:Cigarette Smoking and High Body Mass Index Increase the Risk of AMD 2Health News:Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom 2Health News:Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom 3Health News:Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: